Dexamethasone: Potential Treatment for Covid-19 in Indonesia

KOMPAS.com – As countries around the world continue their search for a Covid-19 vaccine, the drug dexamethasone has been promoted as a potential solution.

Hope for the drug has risen after the World Health Organization announced it halted testing of malaria drug hydroxychloroquine following clinical observations it showed no efficacy on improving the condition of Covid-19 patients.

A team from Oxford University in the United Kingdom hailed dexamethasone as a breakthrough in the fight against the coronavirus on Tuesday, June 16.

The scientists revealed that tests on thousands of Covid-19 patients showed that it reduced fatality rates among those terminally ill from the disease.

Dexamethasone’s characteristics

But before authorities can tout dexamethasone as a miracle cure, questions have arisen about the drug and its characteristics. This is no less the case in Indonesia.

“Dexamethasone is an anti-inflammatory medication that is characterized as a potent drug,” said Dr. Wawaimuli Arozal, the head of the Pharmacology and Therapy department of Universitas Indonesia’s Faculty of Medicine.

Also read: Get to Know More About Cordyceps Militaris for COVID-19 Treatment

“Dexamethasone is classified as a cortisol-steroid medication. It is usually used to treat patients with severe headaches, severe inflammation, and autoimmune diseases,” she said. “Dosage for tablets are usually 0.5 milligrams. But injections vary with the severity of the symptoms.”

Risks for certain medical conditions